Inhibition of sensory irritation during consumption of smokeless tobacco products using a combinatorial approach
Combinations of compounds utilized to minimize the sensory irritating character of non-smokeable tobacco products or non-smokeable products containing tobacco extracts or materials derived from tobacco.
1. A tobacco product comprising:
a smokeless tobacco product selected from the list consisting of chewing tobacco, moist smokeless tobacco and dry snuff;
at least two active ingredients;
wherein the first active ingredient is an antagonist of a nicotinic acetylcholine receptor and the second active ingredient is an antagonist of a TRP ion channel; and
wherein the tobacco product does not comprise mercaptan or curcumin.
2. The tobacco product of claim 1 , wherein the smokeless tobacco product is a pouch or preformed product.
3. The tobacco product of claim 1 , wherein the at least two active ingredients are selected form the list consisting of camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, mono-isobornyl formate, grifolin, neogrifol, albaconol, thapsigargin, yohimbine, synthetic derivatives of resiniferotoxin, analogues of 6-gingerol, tetrahydro-napthols, and/or derivatives and/or combinations thereof.
4. The tobacco product of claim 3 , wherein one of the at least two active ingredients is camphor.
5. The tobacco product of claim 1 , wherein the smokeless tobacco product is at least partially enclosed by a coating and wherein the coating contains one of the at least two active ingredients.
6. The tobacco product of claim 5 , wherein the coating comprises a multi-component polymer solution and wherein at least one component of the coating solution comprises a water-soluble, non-cross-linkable component.
7. The tobacco product of claim 1 , wherein the product further comprises an additive selected from the list consisting of flavorants, preservatives, binder, pH stabilizers, disintegrating agents, cross-linking agents, botanical material, vegetable fibers, sweeteners, humectants, and combinations thereof.
8. The tobacco product of claim 1 , further comprising a third active ingredient.
9. The tobacco product of claim 1 , wherein the at least two active ingredients are present in an amount of about 500 picograms to about 4 milligrams per portion.
10. The tobacco product of claim 1 , wherein at least one of the at least two active ingredients is encapsulated in cyclodextrin.
11. The tobacco product of claim 1 , wherein the smokeless tobacco product is a pouch product comprising an inner filling material comprising tobacco.
12. The tobacco product of claim 11 , wherein the inner filling material further comprises one of the at least two active ingredients selected from the list consisting of camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, mono-isobornyl formate, grifolin, neogrifol, albaconol, thapsigargin, yohimbine, synthetic derivatives of resiniferotoxin, analogues of 6-gingerol, tetrahydro-napthols, and/or derivatives and/or combinations thereof.
13. The tobacco product of claim 12 , wherein the inner filling material further comprises the at least two active ingredients.
14. A method of making a tobacco product comprising:
combining a smokeless tobacco product with at least a first and second active ingredient;
wherein the first active ingredient is an antagonist of a nicotinic acetylcholine receptor and the second active ingredient is an antagonist of a TRP ion channel;
wherein the first and second active ingredients are present in an amount effective to reduce or eliminate sensory irritation arising during use of the product; and
wherein the tobacco product does not comprise mercaptan or curcumin.
15. The method of claim 14 , wherein the first and second active ingredients are selected from the list comprising camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, mono-isobornyl formate, grifolin, neogrifol, albaconol, thapsigargin, yohimbine, synthetic derivatives of resiniferotoxin, analogues of 6-gingerol, tetrahydro-napthols, and/or derivatives and/or combinations thereof.
16. The method of claim 14 , further comprising combining the first and second active ingredients with a non-flavored oily carrier prior to being added to the smokeless tobacco product.
17. The method of claim 14 , wherein the first active ingredient is camphor.
18. The method of claim 14 , wherein the TRP ion channel is selected from the group consisting of a TRPV1 channel and a TRPA1 channel.